New Results
Modeling HIV disease progression and transmission at population-level: The potential impact of modifying disease progression in HIV treatment programs
Jennifer M. Ross, Roger Ying, Connie L. Celum, Jared M. Baeten, Katherine K. Thomas, Pamela M. Murnane, Heidi van Rooyen, James P Hughes, Ruanne Barnabas
doi: https://doi.org/10.1101/097337
Jennifer M. Ross
1Departments of Medicine, University of Washington, Seattle, WA, USA
MD, MPHRoger Ying
6Weill Cornell Medical College, Cornell University, New York, NY, USA;
BSConnie L. Celum
1Departments of Medicine, University of Washington, Seattle, WA, USA
2Departments of Global Health, University of Washington, Seattle, WA, USA
3Departments of Epidemiology, University of Washington, Seattle, WA, USA
MDJared M. Baeten
1Departments of Medicine, University of Washington, Seattle, WA, USA
2Departments of Global Health, University of Washington, Seattle, WA, USA
3Departments of Epidemiology, University of Washington, Seattle, WA, USA
MD, PhDKatherine K. Thomas
2Departments of Global Health, University of Washington, Seattle, WA, USA
MSPamela M. Murnane
2Departments of Global Health, University of Washington, Seattle, WA, USA
3Departments of Epidemiology, University of Washington, Seattle, WA, USA
PhDHeidi van Rooyen
7Human Sciences Research Council, Durban, South Africa;
PhDJames P Hughes
5Departments of Biostatistics, University of Washington, Seattle, WA, USA;
8Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
PhDRuanne Barnabas
1Departments of Medicine, University of Washington, Seattle, WA, USA
2Departments of Global Health, University of Washington, Seattle, WA, USA
3Departments of Epidemiology, University of Washington, Seattle, WA, USA
8Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
MD, DPhilArticle usage
Posted January 06, 2017.
Modeling HIV disease progression and transmission at population-level: The potential impact of modifying disease progression in HIV treatment programs
Jennifer M. Ross, Roger Ying, Connie L. Celum, Jared M. Baeten, Katherine K. Thomas, Pamela M. Murnane, Heidi van Rooyen, James P Hughes, Ruanne Barnabas
bioRxiv 097337; doi: https://doi.org/10.1101/097337
Modeling HIV disease progression and transmission at population-level: The potential impact of modifying disease progression in HIV treatment programs
Jennifer M. Ross, Roger Ying, Connie L. Celum, Jared M. Baeten, Katherine K. Thomas, Pamela M. Murnane, Heidi van Rooyen, James P Hughes, Ruanne Barnabas
bioRxiv 097337; doi: https://doi.org/10.1101/097337
Subject Area
Subject Areas
- Biochemistry (11739)
- Bioengineering (8750)
- Bioinformatics (29189)
- Biophysics (14967)
- Cancer Biology (12093)
- Cell Biology (17409)
- Clinical Trials (138)
- Developmental Biology (9419)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18301)
- Genetics (12238)
- Genomics (16797)
- Immunology (11865)
- Microbiology (28068)
- Molecular Biology (11583)
- Neuroscience (60953)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4957)
- Plant Biology (10425)
- Synthetic Biology (2884)
- Systems Biology (7338)
- Zoology (1651)